SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fortis Healthcare informs about disclosure

23 Feb 2024 Evaluate
In terms of Regulation 30(4) of SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and reference to letter dated November 14, 2023 and December 26, 2023 regarding a material litigation filed by Northern TK Venture, the Promoter shareholder of the Company (NTK), against Daiichi Sankyo Company, before the Tokyo District Court in Japan, Fortis Healthcare has informed that a copy of the announcement released by IHH Parent Company of NTK, to the Bursa, Malaysia and Singapore Stock Exchanges is enclosed. They will inform in case of any material developments on the above matter.

The above information is a part of company’s filings submitted to BSE.

Fortis Healthcare Share Price

926.10 9.55 (1.04%)
22-Apr-2026 12:51 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×